If this is not your name, click here.
| | If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| |  Alupent Inhalation Aerosol Recalled by Boehringer Ingelheim RIDGEFIELD, Conn., April 9, 1996 -- Boehringer Ingelheim Pharmaceuticals, Inc. has initiated a voluntary recall of approximately 8,400 refill canisters of ALUPENT(R) (metaproterenol sulfate) Inhalation Aerosol which were shipped to wholesalers beginning on March 11, 1996. The only canisters being recalled are as follows: ALUPENT Inhalation Aerosol Refill Canisters Patients who have obtained an ALUPENT Inhalation Aerosol refill since March 11, 1996, should check the lot number on the label of their canister and return any with lot number 951051A to their pharmacist for a replacement. The recall was initiated after a single canister of ATROVENT(R) (ipratropium bromide) Inhalation Aerosol was discovered by the Company among the ALUPENT lot #951051A. Company officials believe that this is an isolated case, however, it is continuing its investigation to determine the cause of this situation and to take corrective action to ensure that it cannot recur in the future. Although it is unlikely that any individual patient may receive or has received ATROVENT Inhalation Aerosol mislabeled as ALUPENT Inhalation Aerosol, patients should be aware that the use of this mislabeled ALUPENT Inhalation Aerosol may result in significantly decreased therapeutic response. Patients who possess ALUPENT refills with lot #951051A, and have questions about this recall, should contact either their physicians or feel free to call the Company's toll-free hotline at 1-800-542-6257.
|
